# Vilon

Canonical source: https://retacompare.com/encyclopedia/vilon

Proposed to modulate gene expression in immune tissues and extend lifespan in murine models.

Reference facts

Also known asKE, Lys-GluCategoryKhavinson BioregulatorsMechanism of actionProposed to modulate gene expression in immune tissues and extend lifespan in murine models.TargetsThymic gene expression (proposed)Indications under research or approvedRussian gerontology researchRegulatory status (reference entry)Not FDA-approvedHalf-lifeMinutesSequenceKESequence notesDipeptide developed by Khavinson group as a thymic immunomodulator bioregulator.Molecular weight (Da)275First reported1995
    Primary References

Anisimov et al., Mech Ageing Dev 1998 (Vilon longevity)


    Explore research articles about Vilon


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- Anisimov et al., Mech Ageing Dev 1998 (Vilon longevity): https://pubmed.ncbi.nlm.nih.gov/9842727/